[1]
AVES Editorial Office, “The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia and influence on H. pylori eradication therapy”, Turkish Journal of Gastroenterology, vol. 23, no. 6, pp. 805–806, Jul. 2019.